Interim Analysis of a Double-Blind Phase-III Clinical Trial of Adjuvant Levamisole Versus Control in Resectable Dukes-C Colon Cancer: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group

Combined Modality Therapy of Gastrointestinal Tract Cancer - Recent Results in Cancer Research ◽

10.1007/978-3-642-83293-2_14 ◽

1988 ◽

pp. 101-103 ◽

Cited By ~ 3

Author(s):

J. P. Arnaud ◽

M. Buyse ◽

M. Adloff ◽

B. Nordlinger ◽

J. C. Pector ◽

...

Keyword(s):

Clinical Trial ◽

Colon Cancer ◽

Gastrointestinal Tract ◽

Interim Analysis ◽

Phase Iii ◽

Cooperative Group ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Tract Cancer ◽

Dukes C

Download Full-text

Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in Resectable Gastric Cancer: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group

Combined Modality Therapy of Gastrointestinal Tract Cancer - Recent Results in Cancer Research ◽

10.1007/978-3-642-83293-2_5 ◽

1988 ◽

pp. 36-43 ◽

Cited By ~ 4

Author(s):

M. Lise ◽

D. Nitti ◽

M. Buyse ◽

G. Cartei ◽

A. Fornasiero ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Gastrointestinal Tract ◽

Mitomycin C ◽

Phase Iii ◽

Cooperative Group ◽

Phase Iii Clinical Trial ◽

Tract Cancer ◽

Gastrointestinal Tract Cancer ◽

Resectable Gastric Cancer

Download Full-text

Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the gastrointestinal tract cancer cooperative group of the European organization for research on treatment of cancer (EORTC)

Cancer ◽

10.1002/1097-0142(19850515)55:10<2373::aid-cncr2820551012>3.0.co;2-d ◽

1985 ◽

Vol 55 (10) ◽

pp. 2373-2379 ◽

Cited By ~ 78

Author(s):

André Gerard ◽

Jean-Louis Berrod ◽

Françoise Pene ◽

Jean Loygue ◽

Alain Laugier ◽

...

Keyword(s):

Radiation Therapy ◽

Gastrointestinal Tract ◽

Interim Analysis ◽

Phase Iii ◽

Preoperative Radiation ◽

Cooperative Group ◽

European Organization ◽

Tract Cancer ◽

Gastrointestinal Tract Cancer ◽

Phase Iii Study

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology ◽

10.1093/annonc/mdz402 ◽

2019 ◽

Vol 30 (12) ◽

pp. 1950-1958 ◽

Cited By ~ 20

Author(s):

C. Morizane ◽

T. Okusaka ◽

J. Mizusawa ◽

H. Katayama ◽

M. Ueno ◽

...

Keyword(s):

Clinical Trial ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Tract Cancer

Download Full-text

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase

Download Full-text

Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12429 ◽

2015 ◽

Vol 17 (5) ◽

pp. 511-515 ◽

Cited By ~ 11

Author(s):

S.-M. Jin ◽

S. W. Park ◽

K.-H. Yoon ◽

K. W. Min ◽

K.-H. Song ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.2090 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 769.1-769 ◽

Cited By ~ 3

Author(s):

A.-K. Tausche ◽

R. Alten ◽

N. Dalbeth ◽

J. Kopicko ◽

N. Bhakta ◽

...

Keyword(s):

Clinical Trial ◽

Xanthine Oxidase ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Xanthine Oxidase Inhibitors

Download Full-text

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Cited By ~ 1

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Dust Mite

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Parallel Group

Download Full-text